By Dr Bryce Vissel

Journal articles

Clark IA; Vissel B, 2014, 'Inflammation-sleep interface in brain disease: TNF, insulin, orexin', Journal of Neuroinflammation, 11, http://dx.doi.org/10.1186/1742-2094-11-51

Morris GP; Clark IA; Vissel B, 2014, 'Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/s40478-014-0135-5

Stayte S; Vissel B, 2014, 'Advances in non-dopaminergic treatments for Parkinson's disease', Frontiers in Neuroscience, http://dx.doi.org/10.3389/fnins.2014.00113

Stayte S; Vissel B, 2014, 'Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease', Frontiers in Neuroscience

Morris GP; Clark IA; Vissel B, 2014, 'Inconsistencies and controversies surrounding the Amyloid Hypothesis of Alzheimer¿s disease', Acta Neuropathologica Communications, 2, pp. 135 - 135, http://dx.doi.org/10.1186/preaccept-1342777270140958

Morris GP; Clark IA; Zinn R; Vissel B, 2013, 'Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research', Neurobiology of Learning and Memory, 105, pp. 40 - 53, http://dx.doi.org/10.1016/j.nlm.2013.07.002

Wright AL; Zinn R; Hohensinn B; Konen LM; Beynon SB; Tan RP; Clark IA; Abdipranoto A; Vissel B, 2013, 'Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer's Disease', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0059586

Clark IA; Vissel B, 2013, 'Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease', Biochemical Pharmacology, 86, pp. 862 - 871, http://dx.doi.org/10.1016/j.bcp.2013.07.030

Wright A; Vissel B, 2012, 'The essential role of AMPA receptor GluA2 subunit RNA editing in the normal and diseased brain', Frontiers in Molecular Neuroscience, 5, pp. 34, http://dx.doi.org/10.3389/fnmol.2012.00034

Clark I; Atwood C; Bowen R; Paz-Filho G; Vissel B, 2012, 'Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales', Pharmacological Reviews, 64, pp. 1004 - 1026, http://dx.doi.org/10.1124/pr.112.005850

Gotz J; Schonrock N; Vissel B; Ittner L, 2011, 'Alzheimer's disease selective vulnerability and modelling in transgenic mice', Advances in Alzheimer's Disease, 1, pp. 49 - 58, http://dx.doi.org/10.3233/978-1-60750-733-8-49

McRoberts JA; Ennes HS; Marvizon JCG; Fanselow M; Mayer EA; Vissel B, 2011, 'Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test', Neuroscience, 172, pp. 474 - 482, http://dx.doi.org/10.1016/j.neuroscience.2010.10.045

Clark I; Alleva L; Vissel B, 2011, 'TNF and leptin tell essentially the same story in Alzheimer's disease', Journal of Alzheimer's Disease, 26, pp. 201 - 205, http://dx.doi.org/10.3233/JAD-2011-110266

Wiltgen B; Royle G; Gray E; Abdipranoto A; Thangthaeng N; Jacobs N; Saab F; Tonegawa S; Heinemann SF; O''Dell T; Fanselow M; Vissel B, 2010, 'A role for calcium-permeable AMPA receptors in synaptic plasticity and learning', PLoS One, 5, pp. 1 - 18

Galbraith SA; Daniel JA; Vissel B, 2010, 'A study of clustered data and approaches to its analysis', Journal of Neuroscience, 30, pp. 10601 - 10608

Wright A; Zinn R; Vissel B, 2010, 'P1‐161: Characterization of learning deficits in two models of Alzheimer's disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.05.711

Clark I; Alleva L; Vissel B, 2010, 'The roles of TNF in brain dysfunction and disease', Pharmacology and Therapeutics, 128, pp. 519 - 548

Abdipranoto-Cowley A; Jin SP; Croucher DR; Daniel JA; Henshall SM; Galbraith SA; Mervin K; Vissel B, 2009, 'Activin A is essential for neurogenesis following neurodegeneration', Stem Cells, 27, pp. 1330 - 1346

Goetz J; Schonrock N; Vissel B; Ittner L, 2009, 'Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice', Journal of Alzheimer's Disease, 18, pp. 243 - 251

Daniel JA; Galbraith SA; Iacovitti L; Abdipranoto ; Vissel B, 2009, 'Functional heterogeneity at dopamine release sites', Journal of Neuroscience, 29, pp. 14670 - 14680

Abdipranoto A; Wu S; Stayte S; Vissel B, 2008, 'The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development', CNS and Neurological Disorders - Drug Targets, 7, pp. 187 - 210, http://dx.doi.org/10.2174/187152708784083858

Youn D; Royle G; Kolaj M; Vissel B; Randic M, 2008, 'Enhanced LTP of primary afferent neurotransmission in AMPA receptor GluR2-deficient mice', Pain, 136, pp. 158 - 167, http://dx.doi.org/10.1016/j.pain.2007.07.001

McRoberts JA; Ennes HS; Vissel B; Fanselow MS; Mayer EA, 2008, 'T1442 Tissue Specific Knockdown of NMDA Receptors in Primary Afferent Neurons Decreases Inflammatory Hyperalgesia', Gastroenterology, 134, pp. A - 556, http://dx.doi.org/10.1016/s0016-5085(08)62596-2

Hinshelwood R; Huschtscha L; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells C; Hume DP; Reddel R; Clark SJ, 2007, 'Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis', Cancer research, 67, pp. 11517 - 11527

Gray E; Fink A; Sarinana J; Vissel B; O Dell T, 2007, 'Long-term potentiation in the hippocampal CA1 region does not require insertion and activation of GluR2-lacking AMPA receptors', Journal of Neurophysiology, 98, pp. 2488 - 2492

Thomas CG; Krupp JJ; Bagley EE; Bauzon R; Heinemann SF; Vissel B; Westbrook GL, 2006, 'Probing N-Methyl-D-aspartate receptor desensitization with the substituted-cysteine accesibility method', Molecular Pharmacology, 69, pp. 1296 - 1303

Skvorak K; Vissel B; Homanics GE, 2006, 'Production of conditional point mutant knockin mice', Genesis, 44, pp. 345 - 353

Sonner JM; Vissel B; Royle G; Maurer A; Gong D; Baron NV; Harrison N; Fanselow M; Eger EI, 2005, 'The effect of three inhaled anesthetics in mice harboring mutations in the GluR6 (kainate) receptor gene', Anesthesia and Analgesia, 101, pp. 143 - 148, http://dx.doi.org/10.1213/01.ANE.0000152615.53435.B4

Hauser K; Aldrich J; Anderson KL; Bakalkin G; Hall E; Knapp P; Scheff S; Vissel B; Woods A; Yakovleva T; Shippenberg T; Christie MJ; Singh-Grewal I, 2005, 'Pathobiology of dynorphins in trauma and disease', Frontiers in Bioscience, 10, pp. 216 - 235

Sonner JM; Antognini JF; Dutton RC; Flood P; Gray AT; Harris RA; Homanics GE; Kendig J; Orser B; Raines DE; Rampil IJ; Trudell J; Vissel B; Eger EI, 2004, 'Erratum: Inhaled Anesthetics and Immobility: Mechanisms, Mysteries, and Minimum Alveolar Anesthetic Concentration (Anesthesia and Analgesia (September 2003) 97 (718-740))', Anesthesia and Analgesia, 98, pp. 29

Petralia R; Sans N; Wang YX; Vissel B; Chang KJ; Noben-Trauth K; Heinemann S; Wenthold R, 2004, 'Loss of GLUR2 alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acidreceptor subunit differentially affects remaining synaptic glutamatereceptors in cerebellum and cochlear nuclei', European Journal of Neuroscience, 19, pp. 2017 - 2029

Sans N; Vissel B; Petralia RS; Wang YX; Chang K; Royle GA; Wang CY; O'Gorman S; Heinemann SF; Wenthold RJ, 2003, 'Aberrant Formation of Glutamate Receptor Complexes in Hippocampal Neurons of Mice Lacking the GluR2 AMPA Receptor Subunit', Journal of Neuroscience, 23, pp. 9367 - 9373, http://dx.doi.org/10.1523/jneurosci.23-28-09367.2003

Sonner JM; Antognini JF; Dutton RC; Flood P; Gray AT; Harris RA; Homanics GE; Kendig J; Orser B; Raines DE; Trudell J; Vissel B; Eger EI, 2003, 'Inhaled anesthetics and immobility: Mechanisms, mysteries, and minimum alveolar anesthetic concentration', Anesthesia and Analgesia, 97, pp. 718 - 740, http://dx.doi.org/10.1213/01.ANE.0000081063.76651.33

Sekirnjak C; Vissel B; Bollinger J; Faulstich M; Du Lac S, 2003, 'Purkinje cell synapses target physiologically unique brainstem neurons', Journal of Neuroscience, 23, pp. 6392 - 6398, http://dx.doi.org/10.1523/jneurosci.23-15-06392.2003

South SM; Kohno T; Kaspar BK; Hegarty D; Vissel B; Drake CT; Ohata M; Jenab S; Sailer AW; Malkmus S; Masuyama T; Horner P; Bogulavsky J; Gage FH; Yaksh TL; Woolf CJ; Heinemann SF; Inturrisi CE, 2003, 'A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain', Journal of Neuroscience, 23, pp. 5031 - 5040, http://dx.doi.org/10.1523/jneurosci.23-12-05031.2003

Luo JH; Fu ZY; Losi G; Kim BG; Prybylowski K; Vissel B; Vicini S, 2002, 'Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture', Neuropharmacology, 42, pp. 306 - 318, http://dx.doi.org/10.1016/S0028-3908(01)00188-5

Vissel B; Krupp JJ; Heinemann SF; Westbrook GL, 2002, 'Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-D-aspartate receptors', Molecular Pharmacology, 61, pp. 595 - 605, http://dx.doi.org/10.1124/mol.61.3.595

Kaspar BK; Vissel B; Bengoechea T; Crone S; Randolph-Moore L; Muller R; Brandon EP; Schaffer D; Verma IM; Lee KF; Heinemann SF; Gage FH, 2002, 'Adeno-associated virus effectively mediates conditional gene modification in the brain', Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 2320 - 2325, http://dx.doi.org/10.1073/pnas.042678699

Krupp JJ; Vissel B; Thomas CG; Heinemann SF; Westbrook GL, 2002, 'Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors', Neuropharmacology, 42, pp. 593 - 602, http://dx.doi.org/10.1016/S0028-3908(02)00031-X

Vissel B; Krupp JJ; Heinemann SF; Westbrook GL, 2001, 'A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux', Nature Neuroscience, 4, pp. 587 - 596, http://dx.doi.org/10.1038/88404

Vissel B; Royle GA; Christie BR; Schiffer HH; Ghetti A; Tritto T; Perez-Otano I; Radcliffe RA; Seamans J; Sejnowski T; Wehner JM; Collins AC; O'Gorman S; Heinemann SF, 2001, 'The role of RNA editing of kainate receptors in synaptic plasticity and seizures', Neuron, 29, pp. 217 - 227, http://dx.doi.org/10.1016/S0896-6273(01)00192-1

Masuyama T; Vissel B; Malkmus SA; Heinemann SF; Yaksh TL, 2000, 'Room B, 10/16/2000 2: 00 PM - 4: 00 PM (PS) Altered Nociception in GluR2 AMPA Receptor Subunit Knockout Mice ', Anesthesiology, 93, pp. A - 917, http://dx.doi.org/10.1097/00000542-200009001-00917

Krupp JJ; Vissel B; Thomas CG; Heinemann SF; Westbrook GL, 1999, 'Interactions of calmodulin and α-actinin with the NR1 subunit modulate Ca²⁺-dependent inactivation of NMDA receptors', Journal of Neuroscience, 19, pp. 1165 - 1178, http://dx.doi.org/10.1523/jneurosci.19-04-01165.1999

Krupp JJ; Vissel B; Heinemann SF; Westbrook GL, 1998, 'N-terminal domains in the NR2 subunit control desensitization of NMDA receptors', Neuron, 20, pp. 317 - 327, http://dx.doi.org/10.1016/S0896-6273(00)80459-6

Westbrook GL; Krupp JJ; Vissel B, 1997, 'Cytoskeletal interactions with glutamate receptors at central synapses', Journal of General Physiology, pp. 163 - 175

Westbrook GL; Krupp JJ; Vissel B, 1997, '', , 52, pp. 163 - 175

Krupp JJ; Vissel B; Heinemann SF; Westbrook GL, 1996, 'Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific', Molecular Pharmacology, 50, pp. 1680 - 1688

Trowell HE; Nagy A; Vissel B; Choo KHA, 1993, 'Long-range analyses of the centromeric regions of human chromosomes 13, 14 and 21: Identification of a narrow domain containing two key centromeric DNA elements', Human Molecular Genetics, 2, pp. 1639 - 1649, http://dx.doi.org/10.1093/hmg/2.10.1639

Kalitsis P; Earle E; Vissel B; Shaffer LG; Choo KHA, 1993, 'A chromosome 13-Specific human satellite I DNA subfamily with minor presence on chromosome 21: Further studies on Robertsonian translocations', Genomics, 16, pp. 104 - 112, http://dx.doi.org/10.1006/geno.1993.1147

Choo KHA; Earle E; Vissel B; Kalitsis P, 1992, 'A chromosome 14-specific human satellite III DNA subfamily that shows variable presence on different chromosomes 14', American Journal of Human Genetics, 50, pp. 706 - 716

Back to profile page